Core Points - The company held an emergency board meeting on October 20, 2025, where it was decided that director Wu Xinyan would temporarily assume the roles of chairman and legal representative due to the absence of founder Huang Guorong [1] - The company has a stable management system and mature governance structure, ensuring normal operations while management will enhance operational management [1] - In the first half of 2025, the company reported revenue of 305 million yuan, a year-on-year increase of 23.08%, while net profit attributable to shareholders decreased by 11.77% to 47.77 million yuan [1] Company Overview - The company focuses on the research, production, and sales of dye intermediates, pesticides, and pharmaceutical intermediates, with key products including various nitro compounds and chlorinated pyridine series [1] - Huang Guorong, the founder, has led the company since 2012, focusing on the development of a leading technical system in the industry, culminating in the company's listing on the Shenzhen Stock Exchange in December 2021 [1] Stock Performance - On the trading day following the board meeting, the company's stock opened lower and experienced fluctuations, closing down 0.74% [2] - The stock's trading volume was 102,000 shares, with a total transaction value of 229 million yuan, reflecting a market capitalization of 4.874 billion yuan and a floating market value of 3.619 billion yuan [3][5]
301190,董事长被采取刑事强制措施